Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abbott, 2000, Inflammatory mediators and modulation of blood–brain barrier permeability, Cell. Mol. Neurobiol., 20, 131, 10.1023/A:1007074420772
Abu el Asrar, 1992, Cytokines in the vitreous of patients with proliferative diabetic retinopathy, Am. J. Ophthalmol., 114, 731, 10.1016/S0002-9394(14)74052-8
Adamis, 2008, Immunological mechanisms in the pathogenesis of diabetic retinopathy, Semin. Immunopathol., 30, 65, 10.1007/s00281-008-0111-x
Aiello, 1995, Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins, Proc. Natl. Acad. Sci. U.S.A., 92, 10457, 10.1073/pnas.92.23.10457
Aiello, 1997, Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor, Diabetes, 46, 1473, 10.2337/diab.46.9.1473
Aiello, 2002, The potential role of PKC beta in diabetic retinopathy and macular edema, Surv. Ophthalmol., 47, S263, 10.1016/S0039-6257(02)00391-0
Al-Ahmad, 2009, Maintaining blood–brain barrier integrity: pericytes perform better than astrocytes during prolonged oxygen deprivation, J. Cell. Physiol., 218, 612, 10.1002/jcp.21638
Alam, 2010, Strategy for effective brain drug delivery, Eur. J. Pharm. Sci., 40, 385, 10.1016/j.ejps.2010.05.003
Al-Latayfeh, 2012, Antiangiogenic therapy for ischemic retinopathies, Cold Spring Harb. Perspect. Med., 2, a006411, 10.1101/cshperspect.a006411
Anderson, 1993, Caveolae: where incoming and outgoing messengers meet, Proc. Natl. Acad. Sci. U.S.A., 90, 10909, 10.1073/pnas.90.23.10909
Anderson, 2008, Transendothelial movement and caveolae, Nat. Biotechnol., 26, 380, 10.1038/nbt0408-380
Andrae, 2008, Role of platelet-derived growth factors in physiology and medicine, Genes Dev., 22, 1276, 10.1101/gad.1653708
Anthony, 1997, Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood–brain barrier permeability in rats, Brain, 120, 435, 10.1093/brain/120.3.435
Antonelli-Orlidge, 1989, Influence of pericytes on capillary endothelial cell growth, Am. Rev. Respir. Dis., 140, 1129, 10.1164/ajrccm/140.4.1129
Antonetti, 1998, Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells, Diabetes, 47, 1953, 10.2337/diabetes.47.12.1953
Antonetti, 1999, Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors, J. Biol. Chem., 274, 23463, 10.1074/jbc.274.33.23463
Antonetti, 2002, Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin, J. Neurochem., 80, 667, 10.1046/j.0022-3042.2001.00740.x
Armstrong, 2012, Co-regulation of transcellular and paracellular leak across microvascular endothelium by dynamin and Rac, Am. J. Pathol., 180, 1308, 10.1016/j.ajpath.2011.12.002
Armulik, 2011, Pericytes: developmental, physiological, and pathological perspectives, problems, and promises, Dev. Cell., 21, 193, 10.1016/j.devcel.2011.07.001
Aroca, 2004, Risk factors for diffuse and focal macular edema, J. Diabetes Complications, 18, 211, 10.1016/S1056-8727(03)00038-2
Asahara, 1998, Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization, Circ. Res., 83, 233, 10.1161/01.RES.83.3.233
Ayalon, 1994, Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells, J. Cell Biol., 126, 247, 10.1083/jcb.126.1.247
Balda, 1996, Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein, J. Cell Biol., 134, 1031, 10.1083/jcb.134.4.1031
Bamforth, 1997, Ultrastructural analysis of interleukin-1 beta-induced leukocyte recruitment to the rat retina, Invest. Ophthalmol. Vis. Sci., 38, 25
Barber, 2000, Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes, Invest. Ophthalmol. Vis. Sci., 41, 3561
Barber, 2003, Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats, Invest. Ophthalmol. Vis. Sci., 44, 5410, 10.1167/iovs.03-0244
Bauer, 2004, Proteins of the tight junction in the blood–brain barrier, 1
Bazzoni, 1999, Endothelial adhesion molecules in the development of the vascular tree: the garden of forking paths, Curr. Opin. Cell Biol., 11, 573, 10.1016/S0955-0674(99)00023-X
Bazzoni, 2004, Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis, Physiol. Rev., 84, 869, 10.1152/physrev.00035.2003
Beck, 2009, Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema, Arch. Ophthalmol., 127, 245, 10.1001/archophthalmol.2008.610
Behzadian, 2001, TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function, Invest. Ophthalmol. Vis. Sci., 42, 853
Bell, 2010, Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging, Neuron, 68, 409, 10.1016/j.neuron.2010.09.043
Beltramo, 2002, Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations, Diabetologia, 45, 416, 10.1007/s00125-001-0761-x
Bienz, 2000, Linking colorectal cancer to Wnt signaling, Cell, 103, 311, 10.1016/S0092-8674(00)00122-7
Boado, 2011, The Trojan Horse liposome technology for nonviral gene transfer across the blood–brain barrier, J. Drug Deliv., 2011, 296151, 10.1155/2011/296151
Bobbie, 2010, Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice, Invest. Ophthalmol. Vis. Sci., 51, 3758, 10.1167/iovs.09-4489
Bochaton-Piallat, 2000, TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy, Invest. Ophthalmol. Vis. Sci., 41, 2336
Bolton, 1998, Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo, Neuroscience, 86, 1245, 10.1016/S0306-4522(98)00058-X
Bolton, 2004, Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy, Am. J. Nephrol., 24, 32, 10.1159/000075627
Bosco, 2005, A developmental switch in the expression of aquaporin-4 and Kir4.1 from horizontal to Muller cells in mouse retina, Invest. Ophthalmol. Vis. Sci., 46, 3869, 10.1167/iovs.05-0385
Bradbury, 1985, The blood–brain barrier. Transport across the cerebral endothelium, Circ. Res., 57, 213, 10.1161/01.RES.57.2.213
Braga, 2002, Cell-cell adhesion and signalling, Curr. Opin. Cell Biol., 14, 546, 10.1016/S0955-0674(02)00373-3
Brankin, 2005, Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium, Exp. Eye Res., 81, 22, 10.1016/j.exer.2005.01.005
Bringmann, 2006, Muller cells in the healthy and diseased retina, Prog. Retin. Eye Res., 25, 397, 10.1016/j.preteyeres.2006.05.003
Broekhuizen, 2010, Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus, Diabetologia, 53, 2646, 10.1007/s00125-010-1910-x
Brooks, 2004, Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone, Arch. Ophthalmol., 122, 1801, 10.1001/archopht.122.12.1801
Brosnan, 1989, Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit, J. Neuroimmunol., 25, 227, 10.1016/0165-5728(89)90141-0
Browning, 2008, Diabetic macular edema: what is focal and what is diffuse?, Am. J. Ophthalmol., 146, 649, 10.1016/j.ajo.2008.07.013
Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a
Brownlee, 2005, The pathobiology of diabetic complications: a unifying mechanism, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615
Bruns, 2009, VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis, Biochem. Soc. Trans., 37, 1193, 10.1042/BST0371193
Bruns, 1968, Studies on blood capillaries. II. Transport of ferritin molecules across the wall of muscle capillaries, J. Cell Biol., 37, 277, 10.1083/jcb.37.2.277
Bundgaard, 1979, Endothelial plasmalemmal vesicles as elements in a system of branching invaginations from the cell surface, Proc. Natl. Acad. Sci. U.S.A., 76, 6439, 10.1073/pnas.76.12.6439
Butt, 1990, Electrical resistance across the blood–brain barrier in anaesthetized rats: a developmental study, J. Physiol., 429, 47, 10.1113/jphysiol.1990.sp018243
Cai, 2011, PEDF regulates vascular permeability by a gamma-secretase-mediated pathway, PLoS One, 6, e21164, 10.1371/journal.pone.0021164
Cai, 2011, Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGF-induced vascular permeability, PLoS One, 6, e18076, 10.1371/journal.pone.0018076
Callanan, 2008, Topical nepafenac in the treatment of diabetic macular edema, Clin. Ophthalmol., 2, 689, 10.2147/OPTH.S3965
Campbell, 2008, RNAi-mediated reversible opening of the blood–brain barrier, J. Gene Med., 10, 930, 10.1002/jgm.1211
Campbell, 2010, Systemic delivery of therapeutics to neuronal tissues: a barrier modulation approach, Expert Opin. Drug Deliv., 7, 859, 10.1517/17425247.2010.490554
Carman, 2008, Trans-cellular migration: cell-cell contacts get intimate, Curr. Opin. Cell Biol., 20, 533, 10.1016/j.ceb.2008.05.007
Carson-Walter, 2005, Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis, Clin. Cancer Res., 11, 7643, 10.1158/1078-0432.CCR-05-1099
Cavallaro, 2004, Cell adhesion and signalling by cadherins and Ig-CAMs in cancer, Nat. Rev. Cancer, 4, 118, 10.1038/nrc1276
Cavey, 2008, A two-tiered mechanism for stabilization and immobilization of E-cadherin, Nature, 453, 751, 10.1038/nature06953
Cecchelli, 2007, Modelling of the blood–brain barrier in drug discovery and development, Nat. Rev. Drug Discov., 6, 650, 10.1038/nrd2368
Chen, 2011, Modern methods for delivery of drugs across the blood–brain barrier, Adv. Drug Deliv. Rev., 64, 640, 10.1016/j.addr.2011.11.010
Chen, 2007, High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms, Diabetes, 56, 1559, 10.2337/db06-1103
Chiba, 2008, Transmembrane proteins of tight junctions, Biochim. Biophys. Acta, 1778, 588, 10.1016/j.bbamem.2007.08.017
Choi, 2007, AKAP12 regulates human blood–retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha, J. Neurosci., 27, 4472, 10.1523/JNEUROSCI.5368-06.2007
Chronopoulos, 2011, High glucose-induced altered basement membrane composition and structure increases trans-endothelial permeability: implications for diabetic retinopathy, Curr. Eye Res., 36, 747, 10.3109/02713683.2011.585735
Churdchomjan, 2010, Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control, BMC Endocr. Disord., 10, 5, 10.1186/1472-6823-10-5
Claudio, 1994, Ultrastructural studies of the blood–retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha, Lab. Invest., 70, 850
Collins, 1995, Specific mRNA detection in single lineage-marked blastomeres from preimplantation embryos, Trends Genet., 11, 5, 10.1016/S0168-9525(00)88975-1
Connor, 1989, Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye, J. Clin. Invest., 83, 1661, 10.1172/JCI114065
Cui, 2012, Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response, Exp. Eye Res., 98, 37, 10.1016/j.exer.2012.02.013
Cui, 2007, Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy, Eye (Lond), 21, 200, 10.1038/sj.eye.6702169
Cunha-Vaz, 1983, Studies on the pathophysiology of diabetic retinopathy. The blood–retinal barrier in diabetes, Diabetes, 32, 20, 10.2337/diab.32.2.S20
Cunha-Vaz, 1984, Breakdown of the blood–retinal barriers and cystoid macular edema, Surv. Ophthalmol., 28, 485, 10.1016/0039-6257(84)90230-3
Cunha-Vaz, 1997, The blood–ocular barriers: past, present, and future, Doc. Ophthalmol., 93, 149, 10.1007/BF02569055
D'Amore, 1994, Mechanisms of retinal and choroidal neovascularization, Invest. Ophthalmol. Vis. Sci., 35, 3974
Da, 2004, Aquaporin-4 gene disruption in mice protects against impaired retinal function and cell death after ischemia, Invest. Ophthalmol. Vis. Sci., 45, 4477, 10.1167/iovs.04-0940
Daneman, 2010, Pericytes are required for blood–brain barrier integrity during embryogenesis, Nature, 468, 562, 10.1038/nature09513
Davis, 1996, Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning, Cell, 87, 1161, 10.1016/S0092-8674(00)81812-7
De Bock, 2011, Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood–brain barrier permeability, J. Cereb. Blood Flow Metab., 31, 1942, 10.1038/jcbfm.2011.86
Dejana, 2004, Endothelial cell-cell junctions: happy together, Nat. Rev. Mol. Cell Biol., 5, 261, 10.1038/nrm1357
Dejana, 2008, The role of adherens junctions and VE-cadherin in the control of vascular permeability, J. Cell Sci., 121, 2115, 10.1242/jcs.017897
Dejana, 2012, Vascular endothelial-cadherin and vascular stability, Curr. Opin. Hematol., 19, 218, 10.1097/MOH.0b013e3283523e1c
Deli, 2005, Permeability studies on in vitro blood–brain barrier models: physiology, pathology, and pharmacology, Cell. Mol. Neurobiol., 25, 59, 10.1007/s10571-004-1377-8
DeMaio, 2001, Shear stress regulates occludin content and phosphorylation, Am. J. Physiol. Heart Circ. Physiol., 281, H105, 10.1152/ajpheart.2001.281.1.H105
DeMaio, 2006, Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells, Am. J. Physiol. Heart Circ. Physiol., 290, H674, 10.1152/ajpheart.00554.2005
Demerath, 2004, Telomeres and telomerase in the fetal origins of cardiovascular disease: a review, Hum. Biol., 76, 127, 10.1353/hub.2004.0018
Demircan, 2006, Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy, Eye (Lond), 20, 1366, 10.1038/sj.eye.6702138
Dewever, 2007, Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment, Am. J. Pathol., 171, 1619, 10.2353/ajpath.2007.060968
Diaz-Flores, 2009, Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche, Histol. Histopathol., 24, 909
Distler, 1996, Glia cells of the monkey retina–II. Muller cells, Vis. Res., 36, 2381, 10.1016/0042-6989(96)00005-3
Ditzel, 1976, Oxygen transport impairment in diabetes, Diabetes, 25, 832
Dohgu, 2005, Brain pericytes contribute to the induction and up-regulation of blood–brain barrier functions through transforming growth factor-beta production, Brain Res., 1038, 208, 10.1016/j.brainres.2005.01.027
Dorfel, 2012, Modulation of tight junction structure and function by kinases and phosphatases targeting occludin, J. Biomed. Biotechnol., 2012, 807356
Drab, 2001, Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice, Science, 293, 2449, 10.1126/science.1062688
Dyer, 2000, Control of Muller glial cell proliferation and activation following retinal injury, Nat. Neurosci., 3, 873, 10.1038/78774
Ebnet, 2004, Junctional adhesion molecules (JAMs): more molecules with dual functions?, J. Cell Sci., 117, 19, 10.1242/jcs.00930
Edo, 2005, Aging, telomeres, and atherosclerosis, Cardiovasc. Res., 66, 213, 10.1016/j.cardiores.2004.09.007
Eichler, 2000, VEGF release by retinal glia depends on both oxygen and glucose supply, Neuroreport, 11, 3533, 10.1097/00001756-200011090-00026
El-Mollayess, 2011, Bevacizumab and neovascular age related macular degeneration: pathogenesis and treatment, Semin. Ophthalmol., 26, 69, 10.3109/08820538.2010.545100
Elkin, 2001, Heparanase as mediator of angiogenesis: mode of action, FASEB J., 15, 1661, 10.1096/fj.00-0895fje
Elner, 1998, Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy, Arch. Ophthalmol., 116, 1597, 10.1001/archopht.116.12.1597
Endo, 1999, Water channel (aquaporin 1) expression and distribution in mammary carcinomas and glioblastomas, Microvasc. Res., 58, 89, 10.1006/mvre.1999.2158
Enge, 2002, Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy, EMBO J., 21, 4307, 10.1093/emboj/cdf418
Engelhardt, 2004, Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house?, Eur. J. Immunol., 34, 2955, 10.1002/eji.200425327
Esser, 1998, Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells, J. Cell Sci., 111, 1853, 10.1242/jcs.111.13.1853
Farquhar, 1963, Junctional complexes in various epithelia, J. Cell Biol., 17, 375, 10.1083/jcb.17.2.375
Felinski, 2008, Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element, Exp. Eye Res., 86, 867, 10.1016/j.exer.2008.01.002
Feng, 1999, VEGF-induced permeability increase is mediated by caveolae, Invest. Ophthalmol. Vis. Sci., 40, 157
Feng, 1999, VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells, Biochem. Biophys. Res. Commun., 256, 192, 10.1006/bbrc.1998.9790
Ferrara, 1995, Vascular endothelial growth factor. The trigger for neovascularization in the eye, Lab. Invest., 72, 615
Fisher, 2009, Pericyte signaling in the neurovascular unit, Stroke, 40, S13, 10.1161/STROKEAHA.108.533117
Fletcher, 2008, A review of the role of glial cells in understanding retinal disease, Clin. Exp. Optom., 91, 67, 10.1111/j.1444-0938.2007.00204.x
Forster, 2008, Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood–brain barrier, J. Physiol., 586, 1937, 10.1113/jphysiol.2007.146852
Forsythe, 1996, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1, Mol. Cell. Biol., 16, 4604, 10.1128/MCB.16.9.4604
Frank, 2009, Caveolae and transcytosis in endothelial cells: role in atherosclerosis, Cell. Tissue Res., 335, 41, 10.1007/s00441-008-0659-8
Freddo, 2013, A contemporary concept of the blood–aqueous barrier, Prog. Retin. Eye Res., 32, 181, 10.1016/j.preteyeres.2012.10.004
Fukuda, 2010, Altered expression of aquaporins 1 and 4 coincides with neurodegenerative events in retinas of spontaneously diabetic Torii rats, Exp. Eye Res., 90, 17, 10.1016/j.exer.2009.09.003
Funatsu, 2003, Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema, Ophthalmology, 110, 1690, 10.1016/S0161-6420(03)00568-2
Funatsu, 2005, Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients, Graefes Arch. Clin. Exp. Ophthalmol., 243, 3, 10.1007/s00417-004-0950-7
Funk, 2010, Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab, Retina, 30, 1412, 10.1097/IAE.0b013e3181e095c0
Furuse, 1993, Occludin: a novel integral membrane protein localizing at tight junctions, J. Cell Biol., 123, 1777, 10.1083/jcb.123.6.1777
Furuse, 1998, A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts, J. Cell Biol., 143, 391, 10.1083/jcb.143.2.391
Gaengel, 2009, Endothelial-mural cell signaling in vascular development and angiogenesis, Arterioscler. Thromb. Vasc. Biol., 29, 630, 10.1161/ATVBAHA.107.161521
Gaillard, 2001, Establishment and functional characterization of an in vitro model of the blood–brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes, Eur. J. Pharm. Sci., 12, 215, 10.1016/S0928-0987(00)00123-8
Gao, 2007, Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation, Nat. Med., 13, 181, 10.1038/nm1534
Garcia, 2004, Endothelial cell-astrocyte interactions and TGF beta are required for induction of blood–neural barrier properties, Brain Res. Dev. Brain Res., 152, 25, 10.1016/j.devbrainres.2004.05.008
Gardiner, 1995, Retinal vascular endothelial cell endocytosis increases in early diabetes, Lab. Invest., 72, 439
Gardiner, 2007, Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis, Microcirculation, 14, 25, 10.1080/10739680601072123
Gardner, 1995, Antihistamines reduce blood–retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study, Retina, 15, 134, 10.1097/00006982-199515020-00008
Gardner, 1997, Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells, Invest. Ophthalmol. Vis. Sci., 38, 2423
Gardner, 2002, Diabetic retinopathy: more than meets the eye, Surv. Ophthalmol., 47, S253, 10.1016/S0039-6257(02)00387-9
Gardner, 2006, An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial, Curr. Eye Res., 31, 535, 10.1080/02713680600746112
Gaucher, 2007, Microglial changes occur without neural cell death in diabetic retinopathy, Vis. Res., 47, 612, 10.1016/j.visres.2006.11.017
Gavard, 2006, VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin, Nat. Cell Biol., 8, 1223, 10.1038/ncb1486
Gavard, 2008, Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia, Dev. Cell, 14, 25, 10.1016/j.devcel.2007.10.019
Gerhardt, 2000, N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken, Dev. Dyn., 218, 472, 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#
Gerhardt, 2003, Endothelial-pericyte interactions in angiogenesis, Cell. Tissue Res., 314, 15, 10.1007/s00441-003-0745-x
Geroski, 2000, Drug delivery for posterior segment eye disease, Invest. Ophthalmol. Vis. Sci., 41, 961
Giebel, 2005, Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier, Lab. Invest., 85, 597, 10.1038/labinvest.3700251
Gil, 1980, Fusion of pinocytotic vesicles in liquid filled lungs: a mechanism of cellular damage, Exp. Lung Res., 1, 43, 10.3109/01902148009057512
Gleadle, 1997, Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase, Blood, 89, 503, 10.1182/blood.V89.2.503
Glenn, 2009, The role of advanced glycation end products in retinal ageing and disease, Biochim. Biophys. Acta, 1790, 1109, 10.1016/j.bbagen.2009.04.016
Glenney, 1992, Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts, Proc. Natl. Acad. Sci. U.S.A., 89, 10517, 10.1073/pnas.89.21.10517
Gonzalez-Mariscal, 2008, Crosstalk of tight junction components with signaling pathways, Biochim. Biophys. Acta, 1778, 729, 10.1016/j.bbamem.2007.08.018
Goodyear, 2008, A role for aquaporin-4 during induction of form deprivation myopia in chick, Mol. Vis., 14, 298
Goodyear, 2009, A role for aquaporin-4 in fluid regulation in the inner retina, Vis. Neurosci., 26, 159, 10.1017/S0952523809090038
Gratton, 2004, Caveolae and caveolins in the cardiovascular system, Circ. Res., 94, 1408, 10.1161/01.RES.0000129178.56294.17
Greenwood, 1994, The blood–retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage, Lab. Invest., 70, 39
Gumbiner, 1988, Cadherins: a family of Ca2+-dependent adhesion molecules, Trends Biochem. Sci., 13, 75, 10.1016/0968-0004(88)90040-0
Gumbiner, 1991, Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1, Proc. Natl. Acad. Sci. U.S.A., 88, 3460, 10.1073/pnas.88.8.3460
Gumbiner, 2000, Regulation of cadherin adhesive activity, J. Cell. Biol., 148, 399, 10.1083/jcb.148.3.399
Hallmann, 1995, Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier, Dev. Dyn., 202, 325, 10.1002/aja.1002020402
Hamann, 1998, Aquaporins in complex tissues: distribution of aquaporins 1-5 in human and rat eye, Am. J. Physiol., 274, C1332, 10.1152/ajpcell.1998.274.5.C1332
Hammes, 1991, Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy, Proc. Natl. Acad. Sci. U.S.A., 88, 11555, 10.1073/pnas.88.24.11555
Hammes, 2003, Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy, Nat. Med., 9, 294, 10.1038/nm834
Harhaj, 2004, Regulation of tight junctions and loss of barrier function in pathophysiology, Int. J. Biochem. Cell Biol., 36, 1206, 10.1016/j.biocel.2003.08.007
Harhaj, 2006, VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability, Invest. Ophthalmol. Vis. Sci., 47, 5106, 10.1167/iovs.06-0322
Hasegawa, 1994, Extrarenal tissue distribution of CHIP28 water channels by in situ hybridization and antibody staining, Am. J. Physiol., 266, C893, 10.1152/ajpcell.1994.266.4.C893
Haskins, 1998, ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin, J. Cell Biol., 141, 199, 10.1083/jcb.141.1.199
Hayashi, 1997, Induction of various blood–brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes, Glia, 19, 13, 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.0.CO;2-B
Henry, 1999, Permeation of the luminal capillary glycocalyx is determined by hyaluronan, Am. J. Physiol., 277, H508
Hill, 2008, PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function, Cell, 132, 113, 10.1016/j.cell.2007.11.042
Hinton, 2002, Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy, Eye (Lond), 16, 422, 10.1038/sj.eye.6700190
Hirase, 1997, Occludin as a possible determinant of tight junction permeability in endothelial cells, J. Cell Sci., 110, 1603, 10.1242/jcs.110.14.1603
Hirase, 2001, Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms, J. Biol. Chem., 276, 10423, 10.1074/jbc.M007136200
Hnasko, 2002, Distribution and characterization of plasmalemma vesicle protein-1 in rat endocrine glands, J. Endocrinol., 175, 649, 10.1677/joe.0.1750649
Hofman, 2000, VEGF-A induced hyperpermeability of blood–retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A, Curr. Eye Res., 21, 637, 10.1076/0271-3683(200008)2121-VFT637
Hofman, 2001, Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys, Ophthalmic Res., 33, 156, 10.1159/000055663
Hofman, 2001, Lack of blood–brain barrier properties in microvessels of the prelaminar optic nerve head, Invest. Ophthalmol. Vis. Sci., 42, 895
Hogeboom van Buggenum, 1996, Ocular oxygen measurement, Br. J. Ophthalmol., 80, 567, 10.1136/bjo.80.6.567
Holash, 1999, Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF, Science, 284, 1994, 10.1126/science.284.5422.1994
Hollis, 1992, Astemizole reduces blood–retinal barrier leakage in experimental diabetes, J. Diabetes Complications, 6, 230, 10.1016/1056-8727(92)90057-R
Hori, 2004, A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro, J. Neurochem., 89, 503, 10.1111/j.1471-4159.2004.02343.x
Hosoya, 2010, Lipophilicity and transporter influence on blood–retinal barrier permeability: a comparison with blood–brain barrier permeability, Pharm. Res., 27, 2715, 10.1007/s11095-010-0272-x
Hosoya, 2011, Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood–retinal barrier, Expert Opin. Drug Deliv., 8, 1571, 10.1517/17425247.2011.628983
Hughes, 2004, Vascular leucocyte adhesion molecules unaltered in the human retina in diabetes, Br. J. Ophthalmol., 88, 566, 10.1136/bjo.2003.021204
Hughes, 2007, Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina, Diabetologia, 50, 1089, 10.1007/s00125-007-0621-4
Hughes, 2010, Active HIF-1 in the normal human retina, J. Histochem. Cytochem., 58, 247, 10.1369/jhc.2009.953786
Iandiev, 2007, Diabetes alters the localization of glial aquaporins in rat retina, Neurosci. Lett., 421, 132, 10.1016/j.neulet.2007.04.076
Ikegami-Kawai, 2004, Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats, Glycobiology, 14, 65, 10.1093/glycob/cwh011
Ishii, 1996, Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor, Science, 272, 728, 10.1126/science.272.5262.728
Iyer, 1998, Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha, Genes Dev., 12, 149, 10.1101/gad.12.2.149
Jesaitis, 1994, Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein, J. Cell Biol., 124, 949, 10.1083/jcb.124.6.949
Jiang, 1996, Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1, J. Biol. Chem., 271, 17771, 10.1074/jbc.271.30.17771
Jinga, 2000, Establishment of a pure vascular endothelial cell line from human placenta, Placenta, 21, 325, 10.1053/plac.1999.0492
Joussen, 2001, Leukocyte-mediated endothelial cell injury and death in the diabetic retina, Am. J. Pathol., 158, 147, 10.1016/S0002-9440(10)63952-1
Joussen, 2002, Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo, Am. J. Pathol., 160, 501, 10.1016/S0002-9440(10)64869-9
Joussen, 2004, A central role for inflammation in the pathogenesis of diabetic retinopathy, FASEB J., 18, 1450, 10.1096/fj.03-1476fje
Joussen, 2007, Pathophysiology of diabetic macular edema, Dev. Ophthalmol., 39, 1, 10.1159/000098495
Joussen, 2009, TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations, Mol. Vis., 15, 1418
Kashiwamura, 2011, Hydrocortisone enhances the function of the blood–nerve barrier through the up-regulation of claudin-5, Neurochem. Res., 36, 849, 10.1007/s11064-011-0413-6
Kaur, 2006, Early response of neurons and glial cells to hypoxia in the retina, Invest. Ophthalmol. Vis. Sci., 47, 1126, 10.1167/iovs.05-0518
Kaur, 2008, Blood–retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management, Prog. Retin. Eye Res., 27, 622, 10.1016/j.preteyeres.2008.09.003
Kevil, 1998, Expression of zonula occludens and adherens junctional proteins in human venous and arterial endothelial cells: role of occludin in endothelial solute barriers, Microcirculation, 5, 197, 10.1111/j.1549-8719.1998.tb00069.x
Kim, 2012, Methylglyoxal induces hyperpermeability of the blood–retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases, Graefes Arch. Clin. Exp. Ophthalmol., 250, 691, 10.1007/s00417-011-1912-5
Kim, 2009, Recruitment of pericytes and astrocytes is closely related to the formation of tight junction in developing retinal vessels, J. Neurosci. Res., 87, 653, 10.1002/jnr.21884
Kim, 2005, Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas, Diabetes, 54, 1534, 10.2337/diabetes.54.5.1534
Kimoto, 2012, Anti-vegf agents for ocular angiogenesis and vascular permeability, J. Ophthalmol., 2012, 852183, 10.1155/2012/852183
King, 1985, Receptor-mediated transport of insulin across endothelial cells, Science, 227, 1583, 10.1126/science.3883490
King, 1994, Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus, Annu. Rev. Med., 45, 179, 10.1146/annurev.med.45.1.179
Kita, 2007, Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor, Diabetes, 56, 231, 10.2337/db06-0581
Klaassen, 2009, Altered expression of genes related to blood–retina barrier disruption in streptozotocin-induced diabetes, Exp. Eye Res., 89, 4, 10.1016/j.exer.2009.01.006
Koh, 2002, Biomedical significance of endothelial cell specific growth factor, angiopoietin, Exp. Mol. Med., 34, 1, 10.1038/emm.2002.1
Kojima, 1999, Induction of tight junctions in human connexin 32 (hCx32)-transfected mouse hepatocytes: connexin 32 interacts with occludin, Biochem. Biophys. Res. Commun., 266, 222, 10.1006/bbrc.1999.1778
Kojima, 2002, Cx32 formation and/or Cx32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line, Exp. Cell Res., 276, 40, 10.1006/excr.2002.5511
Komarova, 2010, Regulation of endothelial permeability via paracellular and transcellular transport pathways, Annu. Rev. Physiol., 72, 463, 10.1146/annurev-physiol-021909-135833
Korn, 2002, Neuroectodermal origin of brain pericytes and vascular smooth muscle cells, J. Comp. Neurol., 442, 78, 10.1002/cne.1423
Kucheryavykh, 2007, Downregulation of Kir4.1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes, Glia, 55, 274, 10.1002/glia.20455
Kuiper, 2004, Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina, Br. J. Ophthalmol., 88, 1082, 10.1136/bjo.2003.032045
Kuiper, 2006, Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye, Arch. Ophthalmol., 124, 1457, 10.1001/archopht.124.10.1457
Kuiper, 2007, Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina, Invest. Ophthalmol. Vis. Sci., 48, 4267, 10.1167/iovs.06-0804
Kuiper, 2008, The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy, PLoS One, 3, e2675, 10.1371/journal.pone.0002675
Kuiper, 2008, Connective tissue growth factor is necessary for retinal capillary basal lamina thickening in diabetic mice, J. Histochem. Cytochem., 56, 785, 10.1369/jhc.2008.950980
Kurzchalia, 1992, VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles, J. Cell Biol., 118, 1003, 10.1083/jcb.118.5.1003
Labrecque, 2003, Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol, Mol. Biol. Cell, 14, 334, 10.1091/mbc.E02-07-0379
Lampugnani, 2006, Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments, J. Cell Biol., 174, 593, 10.1083/jcb.200602080
Lampugnani, 2012
Lee, 2011, Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-beta1/ERK/caspase-9 phosphorylation cascade, Mol. Med., 17, 1095, 10.2119/molmed.2011.00106
Lightman, 1992, Effect of lymphocytic infiltration on the blood–retinal barrier in experimental autoimmune uveoretinitis, Clin. Exp. Immunol., 88, 473, 10.1111/j.1365-2249.1992.tb06474.x
Limb, 1996, Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy, Br. J. Ophthalmol., 80, 168, 10.1136/bjo.80.2.168
Lisanti, 1994, Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease, J. Cell Biol., 126, 111, 10.1083/jcb.126.1.111
Liu, 2008, A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization, J. Biol. Chem., 283, 4314, 10.1074/jbc.M707890200
Lorenzi, 1992, Glucose toxicity in the vascular complications of diabetes: the cellular perspective, Diabetes Metab. Rev., 8, 85, 10.1002/dmr.5610080202
Lorenzi, 2001, Early cellular and molecular changes induced by diabetes in the retina, Diabetologia, 44, 791, 10.1007/s001250100544
Lu, 2006, Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation, J. Appl. Physiol., 101, 375, 10.1152/japplphysiol.01515.2005
Luo, 2011, Differential expression of claudins in retinas during normal development and the angiogenesis of oxygen-induced retinopathy, Invest. Ophthalmol. Vis. Sci., 52, 7556, 10.1167/iovs.11-7185
Maisonpierre, 1997, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science, 277, 55, 10.1126/science.277.5322.55
Mandriota, 1998, Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia, Circ. Res., 83, 852, 10.1161/01.RES.83.8.852
Martiney, 1990, Pathophysiologic effect of interleukin-1b in the rabbit retina, Am. J. Pathol., 137, 1411
Martiney, 1992, Chronic inflammatory effects of interleukin-1 on the blood–retina barrier, J. Neuroimmunol., 41, 167, 10.1016/0165-5728(92)90067-U
Matter, 2003, Holey barrier: claudins and the regulation of brain endothelial permeability, J. Cell Biol., 161, 459, 10.1083/jcb.200304039
McAllister, 2009, Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion, Am. J. Ophthalmol., 147, 838, 10.1016/j.ajo.2008.12.006
Medina, 2006, Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection, Infect. Immun., 74, 6665, 10.1128/IAI.00949-06
Mehta, 2006, Signaling mechanisms regulating endothelial permeability, Physiol. Rev., 86, 279, 10.1152/physrev.00012.2005
Milici, 1987, Transcytosis of albumin in capillary endothelium, J. Cell Biol., 105, 2603, 10.1083/jcb.105.6.2603
Milovanova, 2008, Caveolae are an essential component of the pathway for endothelial cell signaling associated with abrupt reduction of shear stress, Biochim. Biophys. Acta, 1783, 1866, 10.1016/j.bbamcr.2008.05.010
Minshall, 2000, Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway, J. Cell Biol., 150, 1057, 10.1083/jcb.150.5.1057
Mitchell, 2011, The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema, Ophthalmololgy, 118, 615, 10.1016/j.ophtha.2011.01.031
Miyake, 2002, Prostaglandins and cystoid macular edema, Surv. Ophthalmol., 47, S203, 10.1016/S0039-6257(02)00294-1
Mizutani, 1996, Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy, J. Clin. Invest., 97, 2883, 10.1172/JCI118746
Morita, 2004, Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease, Br. J. Dermatol., 151, 328, 10.1111/j.1365-2133.2004.06029.x
Motulsky, 2010, Aquaporin expression in blood–retinal barrier cells during experimental autoimmune uveitis, Mol. Vis., 16, 602
Muller, 2011, Mechanisms of leukocyte transendothelial migration, Annu. Rev. Pathol., 6, 323, 10.1146/annurev-pathol-011110-130224
Murakami, 2009, Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability, J. Biol. Chem., 284, 21036, 10.1074/jbc.M109.016766
Murakami, 2012, Protein kinase cbeta phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo, Diabetes, 61, 1573, 10.2337/db11-1367
Murphy-Ullrich, 2000, Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology, Cytokine Growth Factor Rev., 11, 59, 10.1016/S1359-6101(99)00029-5
Murugeswari, 2008, Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease, Retina, 28, 817, 10.1097/IAE.0b013e31816576d5
Musashi, 2005, Thrombin inhibitor reduces leukocyte-endothelial cell interactions and vascular leakage after scatter laser photocoagulation, Invest. Ophthalmol. Vis. Sci., 46, 2561, 10.1167/iovs.04-1102
Myles, 2005, Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis, Adv. Drug Deliv. Rev., 57, 2063, 10.1016/j.addr.2005.08.006
Nagasawa, 2006, Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells, J. Cell. Physiol., 208, 123, 10.1002/jcp.20647
Nagase, 2006, Functional and molecular characterization of adenosine transport at the rat inner blood–retinal barrier, Biochim. Biophys. Acta, 1758, 13, 10.1016/j.bbamem.2006.01.011
Nagelhus, 1999, Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Muller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains, Glia, 26, 47, 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5
Nagelhus, 2004, Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1, Neuroscience, 129, 905, 10.1016/j.neuroscience.2004.08.053
Nakagawa, 2007, Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells, Cell. Mol. Neurobiol., 27, 687, 10.1007/s10571-007-9195-4
Nakagawa, 2009, A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes, Neurochem. Int., 54, 253, 10.1016/j.neuint.2008.12.002
Navaratna, 2007, Proteolytic degradation of VE-cadherin alters the blood–retinal barrier in diabetes, Diabetes, 56, 2380, 10.2337/db06-1694
Negrete, 1996, Permeability properties of the intact mammalian bladder epithelium, Am. J. Physiol., 271, F886
Nielsen, 1993, Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia, Proc. Natl. Acad. Sci. U.S.A, 90, 7275, 10.1073/pnas.90.15.7275
Niemela, 2005, Molecular identification of PAL-E, a widely used endothelial-cell marker, Blood, 106, 3405, 10.1182/blood-2005-01-0254
Nieuwdorp, 2006, Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo, Diabetes, 55, 480, 10.2337/diabetes.55.02.06.db05-1103
Nishikawa, 2000, Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain, Curr. Eye Res., 21, 581, 10.1076/0271-3683(200007)2111-ZFT581
Nitta, 2003, Size-selective loosening of the blood–brain barrier in claudin-5-deficient mice, J. Cell Biol., 161, 653, 10.1083/jcb.200302070
Nusrat, 2000, Tight junctions are membrane microdomains, J. Cell Sci., 113, 1771, 10.1242/jcs.113.10.1771
Nyqvist, 2008, Deciphering the functional role of endothelial junctions by using in vivo models, EMBO Rep., 9, 742, 10.1038/embor.2008.123
Ogunshola, 2012, HIF-1 at the blood–brain barrier: a mediator of permeability?, High Alt. Med. Biol., 13, 153, 10.1089/ham.2012.1052
Oh, 1999, Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells, J. Biol. Chem., 274, 15732, 10.1074/jbc.274.22.15732
Oh, 1998, Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium, J. Cell Biol., 141, 101, 10.1083/jcb.141.1.101
Oh, 2007, Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung, Nat. Biotechnol., 25, 327, 10.1038/nbt1292
Oh, 2010, Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy, Curr. Eye Res., 35, 1116, 10.3109/02713683.2010.510257
Olsson, 2006, VEGF receptor signalling - in control of vascular function, Nat. Rev. Mol. Cell Biol., 7, 359, 10.1038/nrm1911
Orsenigo, 2012, Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo, Nat. Commun., 3, 1208, 10.1038/ncomms2199
Oshitari, 2006, Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability, Diabetes, 55, 86, 10.2337/diabetes.55.01.06.db05-0186
Otero, 2001, Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells, Biochem. J., 359, 567, 10.1042/0264-6021:3590567
Paccola, 2008, Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study), Br. J. Ophthalmol., 92, 76, 10.1136/bjo.2007.129122
Palade, 1953, Fine structure of blood capillaries, J. Appl. Physiol., 24, 1424
Palade, 1968, Structural modulations of plasmalemmal vesicles, J. Cell Biol., 37, 633, 10.1083/jcb.37.3.633
Pannicke, 2006, Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina, Diabetes, 55, 633, 10.2337/diabetes.55.03.06.db05-1349
Paolinelli, 2011, The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery?, Pharmacol. Res., 63, 165, 10.1016/j.phrs.2010.11.012
Pappenheimer, 1951, Filtration, diffusion and molecular sieving through peripheral capillary membranes; a contribution to the pore theory of capillary permeability, Am. J. Physiol., 167, 13, 10.1152/ajplegacy.1951.167.1.13
Paris, 2008, Structural organization of the tight junctions, Biochim. Biophys. Acta, 1778, 646, 10.1016/j.bbamem.2007.08.004
Park, 2002, Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype, Am. J. Pathol., 160, 2207, 10.1016/S0002-9440(10)61168-6
Parton, 2003, Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms, Traffic, 4, 724, 10.1034/j.1600-0854.2003.00128.x
Pascariu, 2004, Correlated endothelial caveolin overexpression and increased transcytosis in experimental diabetes, J. Histochem. Cytochem., 52, 65, 10.1177/002215540405200107
Patel, 2005, Angiopoietin concentrations in diabetic retinopathy, Br. J. Ophthalmol., 89, 480, 10.1136/bjo.2004.049940
Peters, 1991
Pfister, 2008, Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy, Diabetes, 57, 2495, 10.2337/db08-0325
Pfister, 2010, Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia, Acta Diabetol., 47, 59, 10.1007/s00592-009-0099-2
2007, Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial, Arch. Ophthalmol., 125, 318, 10.1001/archopht.125.3.318
Polt, 1994, Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood–brain barrier, Proc. Natl. Acad. Sci. U.S.A, 91, 7114, 10.1073/pnas.91.15.7114
Predescu, 2004, Functional and morphological studies of protein transcytosis in continuous endothelia, Am. J. Physiol. Lung Cell. Mol. Physiol., 287, L895, 10.1152/ajplung.00075.2004
Predescu, 2003, Intersectin regulates fission and internalization of caveolae in endothelial cells, Mol. Biol Cell., 14, 4997, 10.1091/mbc.E03-01-0041
Predescu, 2007, Molecular determinants of endothelial transcytosis and their role in endothelial permeability, Am. J. Physiol. Lung Cell. Mol. Physiol., 293, L823, 10.1152/ajplung.00436.2006
Pruneau, 2010, Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy, Curr. Opin. Invest. Drugs, 11, 507
Quigley, 2007, Prognosis and retinal vessel features, Ophthalmology, 114, 1796, 10.1016/j.ophtha.2007.04.012
Rahman, 2007, Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis, Diabetes Obes. Metab., 9, 767, 10.1111/j.1463-1326.2006.00655.x
Rakoczy, 2010, Characterization of a mouse model of hyperglycemia and retinal neovascularization, Am. J. Pathol., 177, 2659, 10.2353/ajpath.2010.090883
Raleigh, 2011, Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function, J. Cell Biol., 193, 565, 10.1083/jcb.201010065
Rangasamy, 2011, A potential role for angiopoietin 2 in the regulation of the blood–retinal barrier in diabetic retinopathy, Invest. Ophthalmol. Vis. Sci., 52, 3784, 10.1167/iovs.10-6386
Raviola, 1977, The structural basis of the blood–ocular barriers, Exp. Eye Res., 25, 27, 10.1016/S0014-4835(77)80009-2
Razani, 2001, Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities, J. Biol. Chem., 276, 38121, 10.1074/jbc.M105408200
Rehak, 2009, Retinal gene expression and Muller cell responses after branch retinal vein occlusion in the rat, Invest. Ophthalmol. Vis. Sci., 50, 2359, 10.1167/iovs.08-2332
Reichenbach, 2007, Muller cells as players in retinal degeneration and edema, Graefes Arch. Clin. Exp. Ophthalmol., 245, 627, 10.1007/s00417-006-0516-y
Rizzolo, 2011, Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium, Prog. Retin. Eye Res., 30, 296, 10.1016/j.preteyeres.2011.06.002
Rogers, 2010, The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia, Ophthalmology, 117, 313, 10.1016/j.ophtha.2009.07.017
Rosengren, 2006, Transvascular protein transport in mice lacking endothelial caveolae, Am. J. Physiol. Heart Circ. Physiol., 291, H1371, 10.1152/ajpheart.01364.2005
Rothberg, 1990, Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate, J. Cell. Biol., 111, 2931, 10.1083/jcb.111.6.2931
Rothberg, 1992, Caveolin, a protein component of caveolae membrane coats, Cell, 68, 673, 10.1016/0092-8674(92)90143-Z
Roy, 2003, Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats, Diabetes, 52, 1229, 10.2337/diabetes.52.5.1229
Rudini, 2008, VE-cadherin is a critical endothelial regulator of TGF-beta signalling, EMBO J., 27, 993, 10.1038/emboj.2008.46
Ruiter, 1993, Angiogenesis in wound healing and tumor metastasis, Behring Inst. Mitt., 92, 258
Runkle, 2011, The blood–retinal barrier: structure and functional significance, Methods Mol. Biol., 686, 133, 10.1007/978-1-60761-938-3_5
Saadoun, 2002, Increased aquaporin 1 water channel expression in human brain tumours, Br. J. Cancer, 87, 621, 10.1038/sj.bjc.6600512
Sagaties, 1987, The structural basis of the inner blood–retina barrier in the eye of Macaca mulatta, Invest. Ophthalmol. Vis. Sci., 28, 2000
Saitou, 1997, Mammalian occludin in epithelial cells: its expression and subcellular distribution, Eur. J. Cell Biol., 73, 222
Saitou, 1998, Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions, J. Cell Biol., 141, 397, 10.1083/jcb.141.2.397
Samad, 2007, Liposomal drug delivery systems: an update review, Curr. Drug Deliv., 4, 297, 10.2174/156720107782151269
Sander, 2001, Diabetic macular edema: passive and active transport of fluorescein through the blood–retina barrier, Invest. Ophthalmol. Vis. Sci., 42, 433
Santibanez, 2008, Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae, Cardiovasc. Res., 77, 791, 10.1093/cvr/cvm097
Sato, 1995, Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation, Nature, 376, 70, 10.1038/376070a0
Scheppke, 2008, Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits, J. Clin. Invest., 118, 2337
Schlingemann, 1985, Monoclonal antibody PAL-E specific for endothelium, Lab. Invest., 52, 71
Schlingemann, 1988, Differential expression of endotheliumspecific antigen PAL-E in vasculature of brain tumors and preexistent brain capillaries, Ann. N.Y. Acad. Sci., 465, 111, 10.1111/j.1749-6632.1988.tb51434.x
Schlingemann, 1997, Vascular expression of endothelial antigen PAL-E indicates absence of blood-ocular barriers in the normal eye, Ophthalmic Res., 29, 130, 10.1159/000268007
Schlingemann, 1991, Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue, Am. J. Pathol., 138, 1335
Schlingemann, 1997, Role of vascular permeability factor/vascular endothelial growth factor in eye disease, Br. J. Ophthalmol., 81, 501, 10.1136/bjo.81.6.501
Schlingemann, 1999, Increased expression of endothelial antigen PAL-E in human diabetic retinopathy correlates with microvascular leakage, Diabetologia, 42, 596, 10.1007/s001250051200
Schlingemann, 2004, Role of growth factors and the wound healing response in age-related macular degeneration, Graefes Arch. Clin. Exp. Ophthalmol., 242, 91, 10.1007/s00417-003-0828-0
Schnitzer, 1988, Astrocytes in mammalian retina, Prog. Ret. Eye Res., 7, 209, 10.1016/0278-4327(88)90009-0
Schnitzer, 1992, gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis, Am. J. Physiol., 262, H246
Schnitzer, 1995, Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases, J. Biol. Chem., 270, 14399, 10.1074/jbc.270.24.14399
Schubert, 2002, Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-name, restores normal microvascular permeability in Cav-1 null mice, J. Biol. Chem., 277, 40091, 10.1074/jbc.M205948200
Schubert, 2007, Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation, Am. J. Pathol., 170, 316, 10.2353/ajpath.2007.060687
Sfikakis, 2005, Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab, Diabetes Care, 28, 445, 10.2337/diacare.28.2.445
Shajahan, 2004, Role of Src-induced dynamin-2 phosphorylation in caveolae-mediated endocytosis in endothelial cells, J. Biol. Chem., 279, 20392, 10.1074/jbc.M308710200
Shen, 2008, The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state, J. Cell Biol., 181, 683, 10.1083/jcb.200711165
Shen, 2010, Retinal vascular changes after glial disruption in rats, J. Neurosci. Res., 88, 1485, 10.1002/jnr.22317
Shimura, 2008, Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema, Am. J. Ophthalmol., 145, 854, 10.1016/j.ajo.2007.12.031
Shue, 2008, Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood–brain barrier disruption in rodent models, BMC Neurosci., 9, 29, 10.1186/1471-2202-9-29
Siemerink, 2010, Mechanisms of ocular angiogenesis and its molecular mediators, Dev. Ophthalmol., 46, 4, 10.1159/000320006
Silva, 2009, Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy, Semin. Ophthalmol., 24, 93, 10.1080/08820530902800355
Simionescu, 1979, The microvascular endothelium. Segmental differentiation transcytosis: selective distribution of anionic sites, 61
Simionescu, 1988, Receptor-mediated transcytosis of plasma molecules by vascular endothelium, 69
Simionescu, 2009, Endothelial transcytosis in health and disease, Cell Tissue Res., 335, 27, 10.1007/s00441-008-0688-3
Simionescu, 1975, Permeability of muscle capillaries to small heme-peptides. Evidence for the existence of patent transendothelial channels, J. Cell Biol., 64, 586, 10.1083/jcb.64.3.586
Simionescu, 1983, Cellular aspects of transcapillary exchange, Physiol. Rev., 63, 1536, 10.1152/physrev.1983.63.4.1536
Sivaprasad, 2012, Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery, Cochrane Database Syst. Rev., 2, CD004239
Simó, 2010, The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier–implications for the pathogenesis of diabetic retinopathy, J. Biomed. Biotechnol., 2010, 190724, 10.1155/2010/190724
Song, 2007, Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells, Blood, 109, 1515, 10.1182/blood-2006-07-034009
Spindler, 2010, Role of GTPases in control of microvascular permeability, Cardiovasc. Res., 87, 243, 10.1093/cvr/cvq086
Stamatovic, 2006, Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability, J. Biol. Chem., 281, 8379, 10.1074/jbc.M513122200
Stan, 1999, Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein, J. Cell Biol., 145, 1189, 10.1083/jcb.145.6.1189
Stefanec, 2004, How the endothelium and its bone marrow-derived progenitors influence development of disease, Med. Hypotheses, 62, 247, 10.1016/S0306-9877(03)00327-X
Stevenson, 1986, Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia, J. Cell Biol., 103, 755, 10.1083/jcb.103.3.755
Stewart, 1994, Blood–eye barriers in the rat: correlation of ultrastructure with function, J. Comp. Neurol., 340, 566, 10.1002/cne.903400409
Stewart, 2000, Endothelial vesicles in the blood–brain barrier: are they related to permeability?, Cell. Mol. Neurobiol., 20, 149, 10.1023/A:1007026504843
Stitt, 2000, Advanced glycation end products induce blood–retinal barrier dysfunction in normoglycemic rats, Mol. Cell. Biol. Res. Commun., 3, 380, 10.1006/mcbr.2000.0243
Stitt, 2002, The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes, Diabetes, 51, 2826, 10.2337/diabetes.51.9.2826
Strickland, 2005, Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF), J. Pathol., 206, 466, 10.1002/path.1805
Suhler, 2005, A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes, Arch. Ophthalmol., 123, 903, 10.1001/archopht.123.7.903
Suhler, 2009, Infliximab therapy for refractory uveitis: 2-year results of a prospective trial, Arch. Ophthalmol., 127, 819, 10.1001/archophthalmol.2009.141
Sundstrom, 2009, Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach, J. Proteome Res., 8, 808, 10.1021/pr7007913
Suri, 1996, Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis, Cell, 87, 1171, 10.1016/S0092-8674(00)81813-9
Tadayoni, 2003, Erythrocyte and leukocyte dynamics in the retinal capillaries of diabetic mice, Exp. Eye Res., 77, 497, 10.1016/S0014-4835(03)00155-6
Taddei, 2008, Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5, Nat. Cell Biol., 10, 923, 10.1038/ncb1752
Takagi, 2003, Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization, Invest. Ophthalmol. Vis. Sci., 44, 393, 10.1167/iovs.02-0276
Takata, 1992, Ultracytochemical localization of the erythrocyte/HepG2-type glucose transporter (GLUT1) in cells of the blood–retinal barrier in the rat, Invest. Ophthalmol. Vis. Sci., 33, 377
Tao-Cheng, 1987, Tight junctions of brain endothelium in vitro are enhanced by astroglia, J. Neurosci., 7, 3293, 10.1523/JNEUROSCI.07-10-03293.1987
Titchenell, 2012, Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood–retinal barrier dysfunction, Biochem. J., 446, 455, 10.1042/BJ20111961
Toda, 2011, Comparison of drug permeabilities across the blood–retinal barrier, blood–aqueous humor barrier, and blood–brain barrier, J. Pharm. Sci., 100, 3904, 10.1002/jps.22610
Tout, 1993, The role of Muller cells in the formation of the blood–retinal barrier, Neuroscience, 55, 291, 10.1016/0306-4522(93)90473-S
Tretiach, 2005, Effect of Muller cell co-culture on in vitro permeability of bovine retinal vascular endothelium in normoxic and hypoxic conditions, Neurosci. Lett., 378, 160, 10.1016/j.neulet.2004.12.026
Tsukita, 1999, Occludin and claudins in tight-junction strands: leading or supporting players?, Trends Cell Biol., 9, 268, 10.1016/S0962-8924(99)01578-0
Tsukita, 2001, Multifunctional strands in tight junctions, Nat. Rev. Mol. Cell Biol., 2, 285, 10.1038/35067088
Tsukita, 2008, Tight junction-based epithelial microenvironment and cell proliferation, Oncogene, 27, 6930, 10.1038/onc.2008.344
Tuma, 2003, Transcytosis: crossing cellular barriers, Physiol. Rev., 83, 871, 10.1152/physrev.00001.2003
Vacca, 2001, Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma, Br. J. Haematol., 113, 415, 10.1046/j.1365-2141.2001.02738.x
Van Geest, 2010, Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy?, Invest. Ophthalmol. Vis. Sci., 51, 1857, 10.1167/iovs.09-4181
Van Geest, 2012, A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy, Br. J. Ophthalmol., 96, 587, 10.1136/bjophthalmol-2011-301005
Van Itallie, 2006, Claudins and epithelial paracellular transport, Annu. Rev. Physiol., 68, 403, 10.1146/annurev.physiol.68.040104.131404
Verkman, 2006, Roles of aquaporins in kidney revealed by transgenic mice, Semin. Nephrol., 26, 200, 10.1016/j.semnephrol.2006.02.002
Verkman, 2008, Functions of aquaporins in the eye, Prog. Retin. Eye Res., 27, 420, 10.1016/j.preteyeres.2008.04.001
Vestweber, 2008, VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation, Arterioscler. Thromb. Vasc. Biol., 28, 223, 10.1161/ATVBAHA.107.158014
Vestweber, 2009, Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player, Trends Cell Biol., 19, 8, 10.1016/j.tcb.2008.10.001
Vink, 1996, Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries, Circ. Res., 79, 581, 10.1161/01.RES.79.3.581
Vink, 2000, Capillary endothelial surface layer selectively reduces plasma solute distribution volume, Am. J. Physiol. Heart Circ. Physiol., 278, H285, 10.1152/ajpheart.2000.278.1.H285
Vinores, 1990, Ultrastructural localization of blood–retinal barrier breakdown in diabetic and galactosemic rats, J. Histochem. Cytochem., 38, 1341, 10.1177/38.9.2117624
Vinores, 2007, TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage, J. Neuroimmunol., 182, 73, 10.1016/j.jneuroim.2006.09.015
Vinten, 2005, Identification of a major protein on the cytosolic face of caveolae, Biochim. Biophys. Acta, 1717, 34, 10.1016/j.bbamem.2005.09.013
Virgintino, 2002, Expression of caveolin-1 in human brain microvessels, Neuroscience, 115, 145, 10.1016/S0306-4522(02)00374-3
Von Zglinicki, 2000, Role of oxidative stress in telomere length regulation and replicative senescence, Ann. N.Y. Acad. Sci., 908, 99, 10.1111/j.1749-6632.2000.tb06639.x
Vyas, 2001, 230
Wagner, 1983, Endocytosis and exocytosis of transferrin by isolated capillary endothelium, Microvasc. Res., 25, 387, 10.1016/0026-2862(83)90028-6
Wagner, 1991, Transcapillary transport of solute by the endothelial vesicular system: evidence from thin serial section analysis, Microvasc. Res., 42, 139, 10.1016/0026-2862(91)90082-M
Wakabayashi, 2011, Increases of vitreous monocyte chemotactic protein 1 and interleukin 8 levels in patients with concurrent hypertension and diabetic retinopathy, Retina, 31, 1951, 10.1097/IAE.0b013e31820d3cee
Wallez, 2008, Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis, Biochim. Biophys. Acta, 1778, 794, 10.1016/j.bbamem.2007.09.003
Walshe, 2009, TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature, PLoS One, 4, e5149, 10.1371/journal.pone.0005149
Wang, 2004, Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion, J. Biol. Chem., 279, 10279, 10.1074/jbc.M312045200
Wenick, 2012, Diabetic macular edema: current and emerging therapies, Middle East. Afr. J. Ophthalmol., 19, 4, 10.4103/0974-9233.92110
Wheelock, 2003, Cadherins as modulators of cellular phenotype, Annu. Rev. Cell Dev. Biol., 19, 207, 10.1146/annurev.cellbio.19.011102.111135
Wisniewska-Kruk, 2012, A novel co-culture model of the blood–retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes, Exp. Eye Res., 96, 181, 10.1016/j.exer.2011.12.003
Witkin, 2011, Update on nonsurgical therapy for diabetic macular edema, Curr. Opin. Ophthalmol., 22, 185, 10.1097/ICU.0b013e3283459724
Witmer, 2002, Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey, Invest. Ophthalmol. Vis. Sci., 43, 849
Witmer, 2003, Vascular endothelial growth factors and angiogenesis in eye disease, Prog. Retin. Eye Res., 22, 1, 10.1016/S1350-9462(02)00043-5
Witmer, 2004, In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A, J. Histochem. Cytochem., 52, 39, 10.1177/002215540405200105
Wolburg, 2002, Tight junctions of the blood–brain barrier: development, composition and regulation, Vascul. Pharmacol., 38, 323, 10.1016/S1537-1891(02)00200-8
Wolburg, 2003, Localization of claudin-3 in tight junctions of the blood–brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme, Acta Neuropathol., 105, 586, 10.1007/s00401-003-0688-z
Wolburg, 2005, Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact, Acta Neuropathol., 109, 181, 10.1007/s00401-004-0928-x
Wolburg, 2006, The endothelial frontier, 77
Wolburg, 2009, Brain endothelial cells and the glio-vascular complex, Cell Tissue Res., 335, 75, 10.1007/s00441-008-0658-9
Wright, 2002, Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells, Exp. Cell Res., 280, 159, 10.1006/excr.2002.5636
Wu, 2011, Intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group, Retina, 31, 298, 10.1097/IAE.0b013e3181eac7a6
Xia, 1996, Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth, J. Clin. Invest., 98, 2018, 10.1172/JCI119006
Xu, 2009, Para-inflammation in the aging retina, Prog. Retin. Eye Res., 28, 348, 10.1016/j.preteyeres.2009.06.001
Yamada, 1955, The fine structure of the gall bladder epithelium of the mouse, J. Biophys. Biochem. Cytol., 1, 445, 10.1083/jcb.1.5.445
Yan, 2011, Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood–brain barrier damage in a rat model of ischemic stroke, PLoS One, 6, e27798, 10.1371/journal.pone.0027798
Yeh, 2007, Inhibition of hypoxia-induced increase of blood–brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression, Mol. Pharmacol., 72, 440, 10.1124/mol.107.036418
Zhang, 2002, Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy, Diabetes, 51, 3499, 10.2337/diabetes.51.12.3499
Zhang, 2006, Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor, FASEB J., 20, 323, 10.1096/fj.05-4313fje
Ziello, 2007, Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia, Yale J. Biol. Med., 80, 51